Veeva Systems Inc. (VEEV) and BioMarin Pharmaceutical Inc. (BMRN) on Thursday announced a long-term enterprise agreement that extends their existing relationship.
Under the expanded partnership, BioMarin aims to boost speed, agility, and operational efficiency, while enhancing the experience for healthcare professionals and patients by leveraging and providng strategic input on Veeva's software, data, services, and consulting offerings.
"This strategic partnership marks an important next step in our digital evolution," said Alexander Hardy, President and Chief Executive Officer of BioMarin.
"Building on this foundation, I look forward to how we can further support BioMarin as they advance important new medicines and reach even more patients around the world," said Veeva CEO Peter Gassner.
On Wednesday, Veeva Systems shares rose 0.62% to $239.35, while BioMarin shares gained 2.06% to $61.31.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.